Canagliflozin Improves Liver Function in Rats by Upregulating Asparagine Synthetase
Conclusion: CANA significantly alleviated liver injury by activating the AMPK/Nrf2/ATF4 axis and upregulating ASNS expression, indicating its potential for treating patients with type 2 diabetes mellitus with impaired liver function.Pharmacology
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Canagliflozin | Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Invokana | Liver | Sodium | Translocation | Urology & Nephrology